Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK8 | P45983 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.38 |
| ▸ | HTR1A | P08908 | 1/20 | 0.38 |
| ▸ | DRD2 | P14416 | 1/20 | 0.38 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.38 |
| ▸ | CARM1 | Q86X55 | 2/20 | 0.37 |
| ▸ | P2RY1 | P47900 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22488064 | 0.90 | PPOX (0.41) | MAPK8LMNASCN9AP2RY1THRB | |
| SCHEMBL21034418 | 0.88 | MAPK8 (0.44) | MAPK8LMNASCN9AHTR1ADRD2 | |
| SCHEMBL3250748 | 0.87 | MAPK8 (0.43) | MAPK8LMNASCN9AHTR1ADRD2 | |
| SCHEMBL21034914 | 0.85 | MEN1 (0.43) | MAPK8LMNAMAPTTHRBALDH1A1 | |
| SCHEMBL3955026 | 0.85 | ATM (0.42) | MAPK8LMNASCN9AHTR1ADRD2 | |
| SCHEMBL21034417 | 0.84 | LMNA (0.46) | MAPK8LMNASCN9ACARM1P2RY1 | |
| SCHEMBL22487899 | 0.83 | MAPK8 (0.40) | MAPK8LMNASCN9AHTR1ADRD2 | |
| SCHEMBL21035048 | 0.83 | MAPK8 (0.40) | MAPK8LMNASCN9AHTR1ADRD2 | |
| SCHEMBL6639473 | 0.83 | MAPK8 (0.40) | MAPK8LMNASCN9AHTR1ADRD2 | |
| SCHEMBL21034409 | 0.81 | LMNA (0.48) | MAPK8LMNAMAPTTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230345941-A1 | HERBICIDAL PHENYLETHERS | BASF SE (DE) | 2023-11-02 | — | — | US | disclosed |
| US-20200305429-A1 | HERBICIDAL PHENYLETHERS | BASF SE (DE) | 2020-10-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200305429-A1 | HERBICIDAL PHENYLETHERS | DDT, HPD, GSTM2 | MAPK8 4030/4885LMNA 3721/4885SCN9A 3892/4885 |
| US-20230345941-A1 | HERBICIDAL PHENYLETHERS | DDT, HPD, GSTM2 | MAPK8 4030/4885LMNA 3721/4885SCN9A 3892/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.